METHOD FOR PREVENTING ACUTE PANCREATITIS AFTER ENDOSCOPIC RETROGRADE PANCREATOCHOLANGIOGRAPHY AND ENDOSCOPIC PAPILLOSPHINCTEROTOMY

The method for preventing the acute pancreatitis after the endoscopic retrograde pancreatocholangiography and endoscopic papillosphincterotomy consists in the intravenous administration of Octreotid prior to papillosphincterotomy. The drug is administered in the following cases: the obesity, the duc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DRONOV OLEKSII IVANOVYCH, NASTASHENKO IHOR LEONIDOVYCH, KOVALSKA INNA OLEKSANDRIVNA, LIUBENKO DMYTRO LEONIDOVYCH
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE PHYSICS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The method for preventing the acute pancreatitis after the endoscopic retrograde pancreatocholangiography and endoscopic papillosphincterotomy consists in the intravenous administration of Octreotid prior to papillosphincterotomy. The drug is administered in the following cases: the obesity, the ductal hypertension in the pancreatic duct in choledocholithiasis, the stenosing papillitis, the low duodenal ulcer, the location of the greater papilla in the diverticulum, the hyperplasia of the papilla, the wedging of the concrement into the papilla. After papillosphincterotomy ?-amilase is assayed in the blood. When its content exceeds 38 units, Octreotid is used daily for 2-3 days.